Dr Reddys Laboratories (RDY) Long-Term Investments (2017 - 2026)

Dr Reddys Laboratories has reported Long-Term Investments over the past 9 years, most recently at $792.5 million for Q1 2026.

  • For Q1 2026, Long-Term Investments rose 21748.66% year-over-year to $792.5 million; the TTM value through Mar 2026 reached $792.5 million, up 21748.66%, while the annual FY2026 figure was $792.5 million, 1315.18% up from the prior year.
  • Long-Term Investments for Q1 2026 was $792.5 million at Dr Reddys Laboratories, up from -$3.7 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $792.5 million in Q1 2026 and troughed at -$3.7 million in Q1 2025.
  • A 4-year average of $214.6 million and a median of $34.7 million in 2022 define the central range for Long-Term Investments.
  • Biggest five-year swings in Long-Term Investments: crashed 128.71% in 2025 and later soared 21748.66% in 2026.
  • Year by year, Long-Term Investments stood at $56.6 million in 2022, then plummeted by 77.49% to $12.8 million in 2024, then crashed by 128.71% to -$3.7 million in 2025, then soared by 21748.66% to $792.5 million in 2026.
  • Business Quant data shows Long-Term Investments for RDY at $792.5 million in Q1 2026, -$3.7 million in Q1 2025, and $12.8 million in Q1 2024.